ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups

07:00 EDT 13 May 2019 | Xconomy

When a biotech startup is ready to test an experimental therapy it faces a pricey choice: Should it make its drug in-house, or hire a contract manufacturer? The decision is particularly expensive for companies developing complex gene and cell therapies, which need to make large batches of engineered viruses to test their work. A new […]

Original Article: ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups


More From BioPortfolio on "ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...